Literature DB >> 16701827

Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation.

Danielle S W Benoit1, Kristi S Anseth.   

Abstract

Heparin was modified with methacrylate groups, copolymerized with dimethacrylated poly(ethylene glycol), and analyzed as a localized delivery vehicle for bFGF and synthetic extracellular matrix for the differentiation of hMSCs. By deriving cues from molecules normally present in the extracellular matrix (ECM), a complex network of collagens, laminin, fibronectin, glycosaminoglycans, and growth factors, synthetic cell scaffolds can be designed that actively sequester important bioactive signals. Among the glycosaminoglycans, heparin binds reversibly with many proteins, therefore, poly(ethylene glycol) based biomaterials, normally resistant to cell adhesion, functionalized with heparin in order to sequester important proteins, can actively and selectively stimulate desired cell functions. Results demonstrate that methacrylate-modified heparin retained its ability to bind heparin-binding proteins both in solution and when copolymerized with dimethacrylated PEG in a hydrogel. In addition, the heparin functionalized gels can deliver biologically active bFGF for up to 5 weeks. Finally, the gels were examined as a potential scaffold for hMSC culture and were found to promote adhesion, proliferation, and osteogenic differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16701827     DOI: 10.1016/j.actbio.2005.03.002

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  70 in total

1.  Differential effects of substrate modulus on human vascular endothelial, smooth muscle, and fibroblastic cells.

Authors:  Karyn G Robinson; Ting Nie; Aaron D Baldwin; Elaine C Yang; Kristi L Kiick; Robert E Akins
Journal:  J Biomed Mater Res A       Date:  2012-02-28       Impact factor: 4.396

Review 2.  Review physical and chemical aspects of stabilization of compounds in silk.

Authors:  Eleanor M Pritchard; Patrick B Dennis; Fiorenzo Omenetto; Rajesh R Naik; David L Kaplan
Journal:  Biopolymers       Date:  2012-01-23       Impact factor: 2.505

3.  Gelation of Covalently Cross-Linked PEG-Heparin Hydrogels.

Authors:  Kelly M Schultz; Aaron D Baldwin; Kristi L Kiick; Eric M Furst
Journal:  Macromolecules       Date:  2009-07-28       Impact factor: 5.985

Review 4.  Designing synthetic materials to control stem cell phenotype.

Authors:  Krishanu Saha; Jacob F Pollock; David V Schaffer; Kevin E Healy
Journal:  Curr Opin Chem Biol       Date:  2007-07-31       Impact factor: 8.822

Review 5.  Approaches to neural tissue engineering using scaffolds for drug delivery.

Authors:  Stephanie M Willerth; Shelly E Sakiyama-Elbert
Journal:  Adv Drug Deliv Rev       Date:  2007-04-10       Impact factor: 15.470

6.  Covalently attached FGF-2 to three-dimensional polyamide nanofibrillar surfaces demonstrates enhanced biological stability and activity.

Authors:  Alam Nur-E-Kamal; Ijaz Ahmed; Jabeen Kamal; Ashwin N Babu; Melvin Schindler; Sally Meiners
Journal:  Mol Cell Biochem       Date:  2007-11-16       Impact factor: 3.396

Review 7.  Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery.

Authors:  Tobias Miller; Melissa C Goude; Todd C McDevitt; Johnna S Temenoff
Journal:  Acta Biomater       Date:  2013-10-09       Impact factor: 8.947

8.  Peptide- and protein-mediated assembly of heparinized hydrogels.

Authors:  Kristi L Kiick
Journal:  Soft Matter       Date:  2008-01-01       Impact factor: 3.679

9.  Emulating native periosteum cell population and subsequent paracrine factor production to promote tissue engineered periosteum-mediated allograft healing.

Authors:  Michael D Hoffman; Danielle S W Benoit
Journal:  Biomaterials       Date:  2015-03-18       Impact factor: 12.479

10.  Control growth factor release using a self-assembled [polycation:heparin] complex.

Authors:  Blaine J Zern; Hunghao Chu; Yadong Wang
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.